Companies

See how salaries can vary from company to company

Established in 1926, APi Distribution is the leading supplier of commercial, industrial, residential and oil & gas insulation products in the Upper Midwest. APi Distribution, a division of APi, Inc. and part of APi Group Inc., has a proud history of supplying high quality insulation and other construction-related materials to the midwest's finest contractors. We inventory a wide range of insulating products to help control temperature, save energy, and attenuate sound. Our product line includes fiberglass, ceramic blanket, mineral wool, closed cell, calcium silicate, air handling, jacketing (M... view company details

API Heat Transfer has successfully established itself as the market leader in innovative and energy efficient equipment. Our 130-year heritage has been dedicated to designing and delivering world-class heat transfer products for almost every industry. Our reputation is bolstered by our worldwide network of manufacturing facilities and more than 1,600 employees who provide sales, service, and support. Our process is ingrained in our culture and has served customers around the world, including your country. Upon working with us, you'll find our performance sets us apart. With a broad product por... view company details

Mayne Pharma is an ASX listed specialty pharmaceutical Company (ASX: MYX) focused on applying its drug delivery expertise to commercialise branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide. Mayne Pharma's business units are: • U.S. Generic Products - develops, markets and distributes generic products in the US, • U.S. Specialty Brands - develops, markets and distributes specialty branded products in the US, • Metrics Contract Services - provides contract pharmaceutical development, manufacturing an... view company details

Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development. For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago. With an unrelenting drive and a singular focus on cell therapy,... view company details

view company details

Superior Tech is a privately held John Deere OEM supplier located in Lancaster, Pennsylvania. Since 1987, Superior Tech has been developing, marketing and distributing products to extend the usefulness of John Deere Equipment. Our business philosophy is focused on providing our customers with a highquality product. We have experienced significant growth in recent years due to expanded product offerings, new marketing and distribution channels. view company details

Mission Montana Tech through exemplary undergraduate and graduate education, workforce development, research, and service builds on a strong heritage in engineering, science, and technology blending theory with practice in meeting the changing needs of society and the responsible development and use of natural resources. view company details

view company details

view company details

Tappan Street Restaurant Group, Inc. is a restaurants company based out of 3543 Peachtree Industrial Blvd, Duluth, GA, United States. view company details

ARL Bio Pharma provides contract research and testing services for the pharmaceutical sector. view company details

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its therapeutic candidates include luspatercept, which completed Phase III clinical trials for the treatment of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis; Phase II clinical trials for the treatment of patients with transfusion-dependent beta-thalassemia. The company is also developing and sotatercept for the treatment of patients with pulmonary hypertension. In addition, the company is developing... view company details

Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal (GI) disorders in the United States. Its lead product candidate is A4250, an orally administered ileal sodium dependent bile acid transporter (IBAT) inhibitor that is in phase III clinical trial for treating progressive familial intrahepatic cholestasis and phase II clinical trial for treating biliary atresia, alagille syndrome, and other cholestatic liver diseases. The company is also developing Elobixib... view company details

Recro Pharma, Inc. operates as a specialty pharmaceutical company. It operates through two divisions, an Acute Care, and Contract Development and Manufacturing (CDMO). The Acute Care division primarily focuses on developing products for the hospital and other acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has completed two pivotal Phase III clinical efficacy trials, a double-blind placebo-controlled Phase III safety trial, and four Phase II clinical efficacy trials, as well as oth... view company details

MEI Pharma, Inc., a pharmaceutical company, focuses on the clinical development of novel therapies for the treatment of cancer. The company's clinical drug candidate includes Pracinostat, an oral available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes ME-401, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia or follicular lymphoma; ME-344, an isoflavone-derived mitochondrial inhibitor... view company details

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray, which is completed Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded in 2007 and is headquartered in Solana Beach, California. view company details

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. view company details

Cocrystal Pharma, Inc., a clinical stage biotechnology company, engages in discovering and developing various novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. It employs structure-based technologies to create antiviral drugs. The company's products include CC-31244, a Phase IIa ready broad-spectrum novel non-nucleoside replication inhibitor for the treatment of hepatitis C virus; and CC-42344, a novel PB2 inhibitor that is in preclinical development trials for the treatment of influenza. It also has a pipeline of produ... view company details

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its therapeutic candidate pipeline includes ATYR1923 candidate, a fusion protein comprising the immuno-modulatory domain of histidyl tRNA synthetase fused of a human antibody that is in Phase 1b/2a clinical trial for treating patients with interstitial lung diseases (ILDs), such as pulmonary sarcoidosis; and in Phase 1 clinical trial to treat chronic hypersensitivity pneumonitis and connective tissue disease ILD. The company has a colla... view company details

Aktiv Pharma Group brings peace of mind to people at risk and their communities by developing simple-to-use emergency treatment technologies. Initially developed for the military, the ARAI™ is a prefilled auto-injector that uses single-hand, single-step activation. Now, ARAI is being developed to help people with life-threatening conditions in emergency situations, such as hypoglycemia, anaphylaxis and opioid overdose. Aktiv's platform technology has been used in a variety of form factors'including pre-filled syringes, auto-injectors, oral and topical dispensers, and IV transfer systems'which ... view company details